I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
nab-Paclitaxel Plus Durvalumab in Patients With Previously ..:
Morgensztern, Daniel
;
Dols, Manuel Cobo
;
Ponce Aix, Santiago
...
https://www.frontiersin.org/articles/10.3389/fonc.2020.569715/full. , 2021
Link:
http://hdl.handle.net/10668/4015
RT Journal T1
nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
UL https://suche.suub.uni-bremen.de/peid=base-ftintsaludcarlos:oai:repisalud.isciii.es:20.500.12105_18251&Exemplar=1&LAN=DE A1 Morgensztern, Daniel A1 Dols, Manuel Cobo A1 Ponce Aix, Santiago A1 Postmus, Pieter E A1 Bennouna, Jaafar A1 Fischer, Jürgen R A1 Juan-Vidal, Oscar A1 Stewart, David J A1 Ardizzoni, Andrea A1 Bhore, Rafia A1 Wolfsteiner, Marianne A1 Reck, Martin A1 Talbot, Denis A1 Govindan, Ramaswamy A1 Ong, Teng Jin PB Frontiers Media YR 2021 K1 Advanced stage non-small cell lung cancer K1 Durvalumab K1 Immune checkpoint blocker plus chemotherapy K1 nab-paclitaxel K1 Second-line therapy K1 Carcinoma de pulmón de células no pequeñas K1 Puntos de control inmunológico K1 Quimioterapia K1 Humans K1 Female K1 Middle Aged K1 Carcinoma K1 Non-Small-Cell Lung K1 Lung Neoplasms K1 Asthenia K1 Diarrhea K1 Mutation K1 Receptor Protein-Tyrosine Kinases JF https://www.frontiersin.org/articles/10.3389/fonc.2020.569715/full LK http://hdl.handle.net/10668/4015 DO http://hdl.handle.net/10668/4015 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)